Biotechnology Stocks I Performance Guide: AbCellera Biologics Inc. (ABCL)
ABCL has no dividends
Table and Chart of ABCL Performance
See what a $1,000 investment in ABCL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ABCL Returns | |
|---|---|
| Start Date | Jan-29-2021 |
| Start Price | $52.83 |
| End Date | Dec-01-2023 |
| End Price | $4.83 |
| # Prices | 36 |
| Min Date | Oct-31-2023 |
| Min Price | $4.11 |
| Max Date | Jan-29-2021 |
| Max Price | $52.83 |
| Total Return | -90.86% |
| Annualized Return | -54.95% |
| Current Value of $1,000 Purchase | $91 |
| Number Returns | 630 |
| Average Return | -39.80% |
| Number Profitable Returns | 77 |
| Percent Profitable Returns | 12.22% |
| Number Unprofitable Returns | 553 |
| Percent Unprofitable Returns | 87.78% |
| Profitable to Unprofitable Returns Ratio | 0.14 |
| ABCL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,401,521,000 | Price to Sales | 27.81 |
| Earnings per Share | $-0.4400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.185 |
| PRICE DATA | |
| 52 Week High | $11.99 |
| 52 Week Low | $3.87 |
| Analyst Target Price | $22 |
| 50-Day Moving Average | $4.404 |
| 200-Day Moving Average | $6.23 |
| FINANCIAL DATA | |
| Revenue per Share | $0.175 |
| Revenue | $50,391,000 |
| Profit Margin | -256.3% |
| Return on Equity | -0.106% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ABCL Compare Returns with S&P 500
ABCL Trendline Chart